Arrowhead Seperation Engineering Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 6:35 pm

Quick Insight

Arrowhead Separation Engineering Ltd, based in Nasik, Maharashtra, currently trades at ₹81.8 with a market cap of ₹15.3 Cr. The company's P/E ratio stands at 37.3, reflecting a premium relative to its earnings. However, with an ROE of 2.50% and ROCE of 6.07%, Arrowhead's profitability metrics indicate room for improvement. The low OPM of 0.08% raises concerns about operational efficiency. Furthermore, the company's high level of borrowings at ₹5.32 Cr against reserves of ₹14.71 Cr necessitates a prudent debt management strategy. Investors should closely monitor Arrowhead's financial performance and operational efficiency to gauge its long-term sustainability and growth potential in the market.

Competitors of Arrowhead Seperation Engineering Ltd

All Competitor Stocks of Arrowhead Seperation Engineering Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:57 am

Below is a detailed analysis of the quarterly data for Arrowhead Seperation Engineering Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 11.92 Cr.. The value appears strong and on an upward trend. It has increased from 8.40 Cr. (Sep 2024) to 11.92 Cr., marking an increase of 3.52 Cr..
• For Expenses, as of Mar 2025, the value is 11.91 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.30 Cr. (Sep 2024) to 11.91 Cr., marking an increase of 4.61 Cr..
• For Operating Profit, as of Mar 2025, the value is 0.01 Cr.. The value appears to be declining and may need further review. It has decreased from 1.10 Cr. (Sep 2024) to 0.01 Cr., marking a decrease of 1.09 Cr..
• For OPM %, as of Mar 2025, the value is 0.08%. The value appears to be declining and may need further review. It has decreased from 13.10% (Sep 2024) to 0.08%, marking a decrease of 13.02%.
• For Other Income, as of Mar 2025, the value is 0.14 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Sep 2024) to 0.14 Cr., marking an increase of 0.14 Cr..
• For Interest, as of Mar 2025, the value is 0.29 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.14 Cr. (Sep 2024) to 0.29 Cr., marking an increase of 0.15 Cr..
• For Depreciation, as of Mar 2025, the value is 0.01 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.01 Cr..
• For Profit before tax, as of Mar 2025, the value is -0.15 Cr.. The value appears to be declining and may need further review. It has decreased from 0.95 Cr. (Sep 2024) to -0.15 Cr., marking a decrease of 1.10 Cr..
• For Tax %, as of Mar 2025, the value is 93.33%. The value appears to be increasing, which may not be favorable. It has increased from 25.26% (Sep 2024) to 93.33%, marking an increase of 68.07%.
• For Net Profit, as of Mar 2025, the value is -0.30 Cr.. The value appears to be declining and may need further review. It has decreased from 0.71 Cr. (Sep 2024) to -0.30 Cr., marking a decrease of 1.01 Cr..
• For EPS in Rs, as of Mar 2025, the value is -1.60. The value appears to be declining and may need further review. It has decreased from 3.79 (Sep 2024) to -1.60, marking a decrease of 5.39.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:32 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:51 pm

Below is a detailed analysis of the balance sheet data for Arrowhead Seperation Engineering Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 1.87 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.87 Cr..
• For Reserves, as of Mar 2025, the value is 14.71 Cr.. The value appears strong and on an upward trend. It has increased from 14.30 Cr. (Mar 2024) to 14.71 Cr., marking an increase of 0.41 Cr..
• For Borrowings, as of Mar 2025, the value is 5.32 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1.79 Cr. (Mar 2024) to 5.32 Cr., marking an increase of 3.53 Cr..
• For Other Liabilities, as of Mar 2025, the value is 7.38 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.82 Cr. (Mar 2024) to 7.38 Cr., marking an increase of 0.56 Cr..
• For Total Liabilities, as of Mar 2025, the value is 29.28 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 24.78 Cr. (Mar 2024) to 29.28 Cr., marking an increase of 4.50 Cr..
• For Fixed Assets, as of Mar 2025, the value is 0.35 Cr.. The value appears strong and on an upward trend. It has increased from 0.29 Cr. (Mar 2024) to 0.35 Cr., marking an increase of 0.06 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.84 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 0.84 Cr., marking an increase of 0.84 Cr..
• For Other Assets, as of Mar 2025, the value is 28.09 Cr.. The value appears strong and on an upward trend. It has increased from 24.49 Cr. (Mar 2024) to 28.09 Cr., marking an increase of 3.60 Cr..
• For Total Assets, as of Mar 2025, the value is 29.28 Cr.. The value appears strong and on an upward trend. It has increased from 24.78 Cr. (Mar 2024) to 29.28 Cr., marking an increase of 4.50 Cr..

Notably, the Reserves (14.71 Cr.) exceed the Borrowings (5.32 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Arrowhead Seperation Engineering Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 2.21. This value is below the healthy minimum of 5. It has decreased from 13.45 (Mar 24) to 2.21, marking a decrease of 11.24.
• For Diluted EPS (Rs.), as of Mar 25, the value is 2.21. This value is below the healthy minimum of 5. It has decreased from 13.45 (Mar 24) to 2.21, marking a decrease of 11.24.
• For Cash EPS (Rs.), as of Mar 25, the value is 2.36. This value is below the healthy minimum of 3. It has decreased from 11.00 (Mar 24) to 2.36, marking a decrease of 8.64.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 88.61. It has increased from 86.40 (Mar 24) to 88.61, marking an increase of 2.21.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 88.61. It has increased from 86.40 (Mar 24) to 88.61, marking an increase of 2.21.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 108.58. It has decreased from 132.32 (Mar 24) to 108.58, marking a decrease of 23.74.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 6.64. This value is within the healthy range. It has decreased from 19.06 (Mar 24) to 6.64, marking a decrease of 12.42.
• For PBIT / Share (Rs.), as of Mar 25, the value is 6.49. This value is within the healthy range. It has decreased from 18.94 (Mar 24) to 6.49, marking a decrease of 12.45.
• For PBT / Share (Rs.), as of Mar 25, the value is 4.24. This value is within the healthy range. It has decreased from 14.69 (Mar 24) to 4.24, marking a decrease of 10.45.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 2.21. This value is within the healthy range. It has decreased from 10.88 (Mar 24) to 2.21, marking a decrease of 8.67.
• For PBDIT Margin (%), as of Mar 25, the value is 6.11. This value is below the healthy minimum of 10. It has decreased from 14.40 (Mar 24) to 6.11, marking a decrease of 8.29.
• For PBIT Margin (%), as of Mar 25, the value is 5.97. This value is below the healthy minimum of 10. It has decreased from 14.31 (Mar 24) to 5.97, marking a decrease of 8.34.
• For PBT Margin (%), as of Mar 25, the value is 3.90. This value is below the healthy minimum of 10. It has decreased from 11.10 (Mar 24) to 3.90, marking a decrease of 7.20.
• For Net Profit Margin (%), as of Mar 25, the value is 2.03. This value is below the healthy minimum of 5. It has decreased from 8.22 (Mar 24) to 2.03, marking a decrease of 6.19.
• For Return on Networth / Equity (%), as of Mar 25, the value is 2.49. This value is below the healthy minimum of 15. It has decreased from 12.59 (Mar 24) to 2.49, marking a decrease of 10.10.
• For Return on Capital Employeed (%), as of Mar 25, the value is 6.67. This value is below the healthy minimum of 10. It has decreased from 19.18 (Mar 24) to 6.67, marking a decrease of 12.51.
• For Return On Assets (%), as of Mar 25, the value is 1.41. This value is below the healthy minimum of 5. It has decreased from 8.21 (Mar 24) to 1.41, marking a decrease of 6.80.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 0.2. It has decreased from 0.06 (Mar 24) to 0.04, marking a decrease of 0.02.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.30. This value is within the healthy range. It has increased from 0.11 (Mar 24) to 0.30, marking an increase of 0.19.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.75. It has decreased from 1.09 (Mar 24) to 0.75, marking a decrease of 0.34.
• For Current Ratio (X), as of Mar 25, the value is 2.59. This value is within the healthy range. It has decreased from 3.83 (Mar 24) to 2.59, marking a decrease of 1.24.
• For Quick Ratio (X), as of Mar 25, the value is 1.68. This value is within the healthy range. It has decreased from 2.34 (Mar 24) to 1.68, marking a decrease of 0.66.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.44. This value is below the healthy minimum of 4. It has decreased from 1.51 (Mar 24) to 1.44, marking a decrease of 0.07.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.95. This value is below the healthy minimum of 3. It has decreased from 4.49 (Mar 24) to 2.95, marking a decrease of 1.54.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.98. This value is below the healthy minimum of 3. It has decreased from 3.56 (Mar 24) to 1.98, marking a decrease of 1.58.
• For Enterprise Value (Cr.), as of Mar 25, the value is 16.81. It has decreased from 22.82 (Mar 24) to 16.81, marking a decrease of 6.01.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. It has decreased from 0.92 (Mar 24) to 0.82, marking a decrease of 0.10.
• For EV / EBITDA (X), as of Mar 25, the value is 13.54. This value is within the healthy range. It has increased from 6.40 (Mar 24) to 13.54, marking an increase of 7.14.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.65. This value is below the healthy minimum of 1. It has decreased from 0.97 (Mar 24) to 0.65, marking a decrease of 0.32.
• For Price / BV (X), as of Mar 25, the value is 0.80. This value is below the healthy minimum of 1. It has decreased from 1.49 (Mar 24) to 0.80, marking a decrease of 0.69.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.65. This value is below the healthy minimum of 1. It has decreased from 0.97 (Mar 24) to 0.65, marking a decrease of 0.32.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.08 (Mar 24) to 0.03, marking a decrease of 0.05.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness